Abhimanyu Garg, MD
Enriched profileProfessor of Internal Medicine, Director of Metabolic Diseases in the Center for Human Nutrition, Director of Nutrition and Metabolic Diseases Fellowship Program, and Distinguished Chair in Human Nutrition Research at The University of Texas Southwestern Medical Center · The University of Texas Southwestern Medical Center
Abhimanyu Garg is Professor of Internal Medicine, Director of Metabolic Diseases in the Center for Human Nutrition, Director of Nutrition and Metabolic Diseases Fellowship Program, and Distinguished Chair in Human Nutrition Research at The University of Texas Southwestern Medical Center at The University of Texas Southwestern Medical Center. OpenAlex indexes 327 publications with 26,621 citations (h-index 84); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Abhimanyu Garg, MD, is Professor of Internal Medicine, Director of Metabolic Diseases in the Center for Human Nutrition, Director of Nutrition and Metabolic Diseases Fellowship Program, and Distinguished Chair in Human Nutrition Research at The University of Texas Southwestern Medical Center. The public record shows 327 publications with 26,621 citations (h-index 84), centered on Lipid metabolism and disorders, Lipid metabolism and biosynthesis, Diabetes, Cardiovascular Risks, and Lipoproteins. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 4 companies, 12 NIH-funded awards (1995–2026).
- Most recent indexed publication: 2026 · The Journal of clinical endocrinology and metabolism
- Top research focus: Lipid metabolism and disorders
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 200.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
Sponsor: Chiesi Farmaceutici S.p.A.
- Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia
Sponsor: University of Texas Southwestern Medical Center
- Orlistat for the Treatment of Type I Hyperlipoproteinemia
Sponsor: University of Texas Southwestern Medical Center
Industry payments
Updated 18 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Chiesi USA, Inc.Program year20241 payment
- Amryt Pharma Holdings LtdProgram year20234 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.6%PCSK9 Inhibitor27%Praluent Pen60%Repatha Sureclick40%Part D<11 patientsStatin23.2%Rosuvastatin Calcium39%Atorvastatin Calcium35%Pravastatin Sodium27%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
10.4%SGLT2 inhibitor5.2%Jardiance100%Part D<11 patientsLeptin Analog5.2%Myalept100%Part D<11 patientsHormonal (systemic)
10%l-Thyroxine10%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
12 NIH research awards on record, funded 1995–2026 per NIH RePORTER. The latest:
- Autoimmune Basis of Acquired Lipodystrophies
Ut Southwestern Medical Center
FY2026$1,355,902R01DK137904 - Genetic and Metabolic Basis of Familial Lipodystrophies
Ut Southwestern Medical Center
FY2026$821,126R01DK105448 - Genetic and Metabolic Basis of Familial Lipodystrophies
Ut Southwestern Medical Center
FY2025$694,902R01DK105448
Congress activity
Updated 18 Oct 2026
12 congress contributions (1992–2025) across ADA, ENDO per OpenAlex. The most recent:
- SUN-253 The Impact of Mibavademab, a Novel Leptin Receptor Agonist, on Metabolic Parameters in Individuals with Generalized Lipodystrophy
ENDO Annual Meeting
ENDO2025Co-author - FRI054 Partial Lipodystrophy As A Manifestation Of Autoimmune Polyglandular Syndrome 1
ENDO Annual Meeting
ENDO2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Genotype-phenotype heterogeneity among patients with lipodystrophy harboring rare POLD1 variants.
The Journal of clinical endocrinology and metabolism
Article2026 - Emery-Dreifuss muscular dystrophy and familial partial lipodystrophy, Dunnigan variety due to heterozygous LMNA variants.
Journal of the Endocrine Society
Article2026 - Clinical Features, Metabolic and Autoimmune Derangements in Acquired Partial Lipodystrophy (Barraquer-Simons Syndrome).
The Journal of clinical endocrinology and metabolism
Article2025 - Novel and Ultrarare Heterozygous Missense LMNA Variants Causing Familial Partial Lipodystrophy.
The Journal of clinical endocrinology and metabolism
Article2025 - Efficacy and Safety of Obeticholic Acid for Treating Hepatic Steatosis in Patients With Familial Partial Lipodystrophy.
The Journal of clinical endocrinology and metabolism
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01Leptin-Replacement Therapy for LipodystrophyArticle1,247 citations2002
- 02
- 03Beneficial Effects of High Dietary Fiber Intake in Patients with Type 2 Diabetes MellitusArticle1,129 citations2000
- 04Acquired and Inherited LipodystrophiesArticle941 citations2004
- 05Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivoArticle688 citations1999
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗
- Board Certification in Endocrinology
Diabetes, and Metabolism
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Jing Chen, MD
The University of Texas Southwestern Medical Center
Raksha Jain, MD
The University of Texas Southwestern Medical Center
Seemal Desai, MD
The University of Texas Southwestern Medical Center
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School